NCT04645199 2026-02-12NICHEInstitute of Hematology & Blood Diseases Hospital, ChinaRecruiting2,300 enrolled
NCT05228470 2026-01-06A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.PfizerPhase 2 Completed39 enrolled 15 charts